A Randomized Controlled Trial to Determine Outcome and Cost Effectiveness of Case Management of Chronic Obstructive Pulmonary Disease (COPD) Patients

Sponsor
Kronikerenheden Nordjylland (Other)
Overall Status
Completed
CT.gov ID
NCT01512836
Collaborator
(none)
150
1
2
18
8.3

Study Details

Study Description

Brief Summary

This randomized controlled trial (RCT) will examine a nurse case management model for patients suffering from chronic obstructive pulmonary disease (COPD) in a Danish municipality, and is performed in order to evaluate the use of case management as a tool in achieving integrated, quality and cost-effective care for this group of patients.

The main objectives are to evaluate how case management influences on hospital admissions, mortality, quality of life and self care, as well as to compare costs and cost-effectiveness of case management vs. usual care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Case Management
N/A

Detailed Description

Case management is being implemented as a health service strategy that should contribute to maximize health outcomes within a cost-constrained environment. Evaluations of case management in Danish settings are sparse, and so far no Danish studies have evaluated the cost-effectiveness of case management.

This study is performed as a RCT, and the study focuses exclusively on patients with COPD. The patients will be enrolled and randomized after being referred to rehabilitation at the local rehabilitation center in Aalborg municipality, Denmark. 150 patients will be randomly assigned to two groups of 75 patients each. Participants in the control group will receive usual care, whereas patients assigned to the interventional group will receive case management besides their usual care. Each patient will be followed for 12 months. Patients in both groups will fill out questionnaires at baseline and 12 months. The data register system "Health - Planning and Quality" in the Northern Region of Jutland will be used to determine health care services and costs.

Study Design

Study Type:
Interventional
Actual Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Randomized Controlled Trial to Determine Outcome and Cost Effectiveness of Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease (COPD) in a Danish Setting
Study Start Date :
Jul 1, 2012
Actual Primary Completion Date :
Jan 1, 2014
Actual Study Completion Date :
Jan 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Case Management

The patients who are randomized to the intervention group will be assigned to case management. The case manager is expected to integrate care from a health maintenance and promotion perspective, where the overall goal is the promote and support the patients self care (see intervention description).

Behavioral: Case Management
Patients, who are randomized to the intervention group, will receive case management from a trained and experienced nurse. The case manager will carry out following tasks: Formulation and implementation of care plans together with the patient Monitoring of individual status and care plan effectuation Overall coordination between health care providers Support to the patient and their caregivers during times of transition related to health status and environmental changes (e.g. hospital to home) Regular telephone consultations and home visits Promote disease-self management through coaching
Other Names:
  • Care management, integrated care, shared care
  • No Intervention: Usual Care

    Patients randomized to the usual care group will receive conventional health and social services. Patients in this group will not receive support from a case manager.

    Outcome Measures

    Primary Outcome Measures

    1. COPD hospitalization rates [1 year (study inclusion - 12 months of follow-up)]

    Secondary Outcome Measures

    1. Mortality [1 year (study inclusion - 12 months of follow-up)]

    2. Self Care [A baseline measure at study inclusion and after 12 months of follow-up]

      The Patient-Activation Measure short form (PAM-13) will be used to evaluate change in self care. The investigators will obtain 2 measurements from each patient during the study period.

    3. Quality of Life (QoL) [A baseline measure at study inclusion and after 12 months of follow-up]

      The investigators will obtain 2 measurements from each patient and are therefore able to evaluate the change in Qol from baseline to end of study (1 year in total). Both generic (EQ-5D, SF-12) and disease-specific questionnaires (Sct. George Respiratory questionnaire, SG-RQ) will be used.

    4. Cost-effectiveness of case management [1 year]

      The cost-effectiveness analysis will examine and compare the cost of health care resources and health outcomes between the two groups. The costs will include all health care utilization during the 1 year of follow-up. Quality adjusted life years (QALYs) is the preferred measure for cost-effectivenes analysis. QALYs will be calculated based on the EuroQol (EQ-5D).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients who are clinically referred to rehabilitation at Aalborg Rehabilitation Center for their diagnosed COPD
    Exclusion Criteria:
    • Patients living outside Aalborg municipality, or who is considering to move to another municipality or country in near future.

    • Patients without a telephone

    • Patients with dementia

    • Patients participating in other research studies

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kronikerenheden, Nordjylland Aalborg Denmark 9000

    Sponsors and Collaborators

    • Kronikerenheden Nordjylland

    Investigators

    • Principal Investigator: Sabrina S Sørensen, Ph.d., Kronikerenheden Nordjylland

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sabrina Storgaard Soerensen, Ph.d. student, Kronikerenheden Nordjylland
    ClinicalTrials.gov Identifier:
    NCT01512836
    Other Study ID Numbers:
    • RN-1
    First Posted:
    Jan 19, 2012
    Last Update Posted:
    Apr 1, 2015
    Last Verified:
    Mar 1, 2015
    Keywords provided by Sabrina Storgaard Soerensen, Ph.d. student, Kronikerenheden Nordjylland
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 1, 2015